Physician profile
Heidi J Oster
NPI 1902863541
$7,870.94
in general payments reported to CMS, 2019-2025
46 companies · $929 in 2025
The $929 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $324 · 2021: $834 · 2022: $3,260 · 2023: $996 · 2024: $1,165 · 2025: $929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,990 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,990.21 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,395.39 | 2022-2024 | Da Vinci Surgical System |
| Abbvie INC. | $1,028.72 | 2019-2025 | |
| Hologic Sales and Service, LLC | $992.59 | 2019-2025 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Organon LLC | $374.44 | 2021-2025 | Nexplanon |
| Coopersurgical, INC. | $272.95 | 2019-2024 | Summit Doppler, Paragard T 380a, Paragard T 380a |
| Mayne Pharma Commercial LLC | $267.57 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $239.73 | 2022-2025 | |
| Exeltis, USA INC. | $223.23 | 2020-2025 | Slynd |
| Astellas Pharma US INC | $209.96 | 2023-2025 | Veozah |
| Coloplast Corp | $160.75 | 2024 | |
| Medtronic, INC. | $137.17 | 2024 | Abre |
| Myovant Sciences INC. | $120.00 | 2021-2022 | |
| Tempus Ai, INC | $117.37 | 2024 | |
| Amneal Pharmaceuticals LLC | $110.26 | 2023-2025 | Unithroid |
| Channel Medsystems, INC. | $96.06 | 2022 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $94.32 | 2022-2025 | Pico, Stravix |
| Therapeuticsmd, INC. | $94.00 | 2019-2022 | |
| Avion Pharmaceuticals | $81.70 | 2021-2023 | Balcoltra |
| Exact Sciences Corporation | $78.44 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $66.55 | 2020-2024 | Gardasil, Gardasil 9 |
| Sumitomo Pharma America, INC. | $65.02 | 2023-2025 | Myfembree |
| Pfizer INC. | $59.58 | 2022-2023 | |
| Sage Therapeutics, LLC | $49.11 | 2024-2025 | Zurzuvae |
| Ascend Therapeutics US, LLC | $40.99 | 2019-2021 | |
| Minerva Surgical, INC | $39.56 | 2024-2025 | |
| C. R. Bard, INC. & Subsidiaries | $37.60 | 2022-2024 | Bd Onclarity |
| Mimedx Group, INC. | $37.39 | 2024 | |
| Aspira Women'S Health INC | $31.53 | 2020 | |
| Allergan, INC. | $27.26 | 2019-2020 | |
| Medicem INC. | $26.68 | 2023 | |
| Meditrina | $26.45 | 2021 | |
| Roche Diagnostics Corporation | $24.89 | 2021 | |
| Becton, Dickinson and Company | $23.04 | 2024 | Bd Onclarity |
| Avanos Medical | $22.62 | 2023 | On-Q* Pump and Accessories |
| Sanofi Pasteur INC. | $22.03 | 2025 | |
| Novo Nordisk INC | $19.85 | 2023 | Saxenda, Wegovy |
| Ibsa Pharma INC. | $18.81 | 2025 | Tirosint, Licart, Flector |
| Lupin INC. | $18.67 | 2021 | |
| Currax Pharmaceuticals LLC | $17.54 | 2025 | Contrave |
| Shield Therapeutics INC | $16.26 | 2024 | |
| Idorsia Pharmaceuticals US INC | $15.82 | 2024 | Quviviq |
| Lsi Solutions INC | $15.54 | 2025 | Fornisee |
| Gynesonics, INC. | $14.56 | 2022 | |
| Innovation Technologies INC | $13.81 | 2025 | Irrisept |
| Teleflex LLC | $13.43 | 2022 | |
| Dysis Medical, INC. | $11.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Oster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.